Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
2101	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	80
2102	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	66
2103	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	31
2104	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	32
2105	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	61
2106	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	64
2107	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	10
2108	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	67
2109	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	57
2110	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	55
2111	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	68
2112	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	61
2113	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	17
2114	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	46
2115	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	34
2116	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	39
2117	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	53
2118	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	63
2119	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	22
2120	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	56
2121	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	42
2122	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	66
2123	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	52
2124	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Poland	13
2125	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	32
2126	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	61
2127	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	72
2128	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	55
2129	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	57
2130	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	62
2131	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	46
2132	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	63
2133	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	65
2134	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	71
2135	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	53
2136	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	57
2137	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	50
2138	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	32
2139	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2021	Standard Therapy	Germany	71
2140	Apheresis	Allogeneic	Acute Myeloid Leukemia – Relapse	Hematology	2021	Standard Therapy	Germany	65
2141	Apheresis	Autologous	Amyloidosis	Hematology	2021	Standard Therapy	Germany	63
2142	Apheresis	Allogeneic	Anaplastic Large Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	56
2143	Apheresis	Autologous	Angioimmunoblastic T-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	62
2144	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2021	Standard Therapy	Poland	54
2145	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2021	Standard Therapy	Poland	7
2146	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2021	Standard Therapy	Poland	40
2147	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2021	Standard Therapy	Poland	14
2148	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2021	Standard Therapy	Poland	36
2149	Apheresis	Autologous	B-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	59
2150	Apheresis	Autologous	B-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	33
2151	Apheresis	Autologous	B-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	63
2152	Apheresis	Autologous	B-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	49
2153	Apheresis	Allogeneic	Chronic Granulomatous Disease	Hematology	2021	Standard Therapy	Poland	28
2154	Apheresis	Allogeneic	Chronic Granulomatous Disease	Hematology	2021	Standard Therapy	Poland	11
2155	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2021	Standard Therapy	Poland	62
2156	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2021	Standard Therapy	Poland	60
2157	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2021	Standard Therapy	Poland	63
2158	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	52
2159	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	45
2160	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	37
2161	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	62
2162	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	64
2163	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	74
2164	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	31
2165	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	63
2166	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2021	Standard Therapy	Poland	18
2167	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	68
2168	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	59
2169	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	67
2170	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	62
2171	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	34
2172	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	70
2173	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2021	Standard Therapy	Poland	71
2174	Apheresis	Allogeneic	Chronic Neutrophilic Leukemia	Hematology	2021	Standard Therapy	Germany	67
2175	Apheresis	Allogeneic	Diffuse Large B-Cell Lymphoma	Hematology	2021	Standard Therapy	Poland	62
2176	Apheresis	Allogeneic	Diffuse Large B-Cell Lymphoma	Hematology	2021	Standard Therapy	Poland	50
2177	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	68
2178	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	63
2179	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma – Relapse	Hematology	2021	Standard Therapy	Germany	65
2180	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma – Relapse	Hematology	2021	Standard Therapy	Germany	65
2181	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma – Relapse	Hematology	2021	Standard Therapy	Germany	71
2182	Apheresis	Allogeneic	Farber Disease	Hematology	2021	Standard Therapy	Poland	9
2183	Apheresis	Allogeneic	Follicular Lymphoma	Hematology	2021	Standard Therapy	Poland	54
2184	Apheresis	Autologous	Follicular Lymphoma	Hematology	2021	Standard Therapy	Germany	55
2185	Apheresis	Autologous	Follicular Lymphoma	Hematology	2021	Standard Therapy	Germany	64
2186	Apheresis	Autologous	Follicular Lymphoma	Hematology	2021	Standard Therapy	Germany	50
2187	Apheresis	Autologous	Germ Cell Tumor	Hematology	2021	Standard Therapy	Germany	28
2188	Apheresis	Allogeneic	Hemophagocytic Lymphohistiocytosis (Hlh)	Hematology	2021	Standard Therapy	Poland	23
2189	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Poland	41
2190	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Poland	40
2191	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Poland	27
2192	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Poland	19
2193	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Poland	26
2194	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Poland	32
2195	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Germany	21
2196	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Germany	37
2197	Apheresis	Autologous	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Germany	30
2198	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Germany	47
2199	Apheresis	Autologous	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Germany	36
2200	Apheresis	Autologous	Hodgkin Lymphoma	Hematology	2021	Standard Therapy	Germany	30

Previous

Page 22 of 72 1 20 21 22 23 24 72

Next